Why is Marksans Pharma falling/rising?

As of 28-Jul, Marksans Pharma Ltd is experiencing a decline in its stock price, currently at 226.45, which reflects a decrease of 1.55 or 0.68%. The stock has been underperforming, having fallen for the last nine consecutive days, resulting in a total decline of 13.57% during this period. Additionally, the stock has underperformed its sector by 0.76% today. Over the past week, it has decreased by 8.87%, and in the last month, it has dropped 10.55%. Despite a high intraday peak of Rs 234.85, the stock is trading below all its moving averages, indicating a bearish trend. While the company boasts high management efficiency and significant institutional holdings, it faces challenges such as poor long-term growth and flat results, which may contribute to the recent price decline.
In the broader market context, the Sensex has also seen a slight decline of 1.59% over the past week, which suggests that the market sentiment is generally negative. However, Marksans Pharma's year-to-date performance shows a significant underperformance of 23.56% compared to the Sensex's gain of 3.52%. This stark contrast highlights the stock's struggles relative to the overall market. The company’s low debt-to-equity ratio and consistent returns over the past three years are positive factors, but they are overshadowed by concerns regarding its operating profit growth and valuation metrics, which may lead investors to be cautious, further impacting the stock's price negatively.